New triplet therapies show promise for relapsed and newly diagnosed leukemias

Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant positive results from novel triplet therapies in the treatment of relapsed or refractory and newly diagnosed leukemias.

Early Intratracheal Budesonide Didn’t Improve Outcomes for Preterm Infants

In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial

November 12, 2024

CMN-005 by CoImmune for Splenic Marginal Zone B-Cell Lymphoma: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

September 10, 2024

Mass General Brigham Launches Healthcare AI Challenge

What You Should Know: – Forward, a technology-driven preventive primary care provider, has announced the immediate closure of all its locations and the shutdown of

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.